Chaga Mushroom for Cholesterol Management

Research suggests that certain compounds found in chaga mushroom, particularly inotodiol, may have a beneficial effect on lipid profiles, based on preclinical animal evidence. The available evidence consists of a single rat study investigating inotodiol in animals with both induced type 2 diabetes and breast cancer, which reported improvements in blood lipid levels alongside reductions in blood glucose. This body of evidence is extremely limited in scope and quality for the specific purpose of cholesterol management, as it relies on one non-human study conducted in a complex disease model rather than a straightforward lipid-focused investigation. Until controlled human trials are conducted, the applicability of these findings to cholesterol management in people remains unknown.